Drawing for DIAPEUTIC

USPTO serial 74326040

DIAPEUTIC

Reviewed by CopyMark Law Group

Reg. 1885732Status 710
Filing date
Status date
Registration date
Mar 28, 1995
Examiner
MULLEN, MARK
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with DIAPEUTIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kathy J. McKnight

KATHY J MCKNIGHT BANNER, BIRCH, MCKIE & BECKETTELEVENTH FL1001 G ST N WWASHINGTON, DC 20001-4597

Goods and services

ClassDescriptionStatusFirst use
001chemicals, biochemicals and enzymes for use in science, photography, agriculture, horticulture, forestry and general industrial use; laboratory chemicals; namely, diagnostic preparations for scientific, research, industrial or private use; chemicals and biochemicals used in immunoassays for scientific, research, industrial or private useSECTION 8 - CANCELLED—
005full line of pharmaceuticals for the treatment of congenital, neoplastic, infective, traumatic, metabolic, endocrine, cardio-vascular, hematological, degenerative, auto immune, inflammatory, allergic, poisoning, iatrogenic, respiratory, gastro intestinal, neurological, dermatological, muscular, renal, urological and reproductive diseases, disorders or conditions; oral, foam, intramuscular and intravenous contraceptives; veterinary substances and preparations for the treatment of domestic and domesticated animals; immunoglobulins, multi-specific antibodies and substances having the effect of antibodies for use in the treatment of congenital, neoplastic, infective, traumatic, metabolic, endocrine, cardio-vascular, hematological, degenerative, auto immune, inflammatory, allergic, poisoning, iatrogenic, respiratory, gastro intestinal, neurological, dermatological, muscular, renal, urological and reproductive diseases, disorders or conditions; diagnostic preparations for diagnosis of congenital, neoplastic, infective, traumatic, metabolic, endocrine, cardio-vascular, hematological, degenerative, auto immune, inflammatory, allergic, poisoning, iatrogenic, respiratory, gastro intestinal, neurological, dermatological, muscular, renal, urological and reproductive diseases, disorders or conditions; chemical substances, diagnostic preparations and reagents all in kit form for diagnosis of congenital, neoplastic, infective, traumatic, metabolic, endocrine, cardio-vascular, hematological, degenerative, auto immune, inflammatory, allergic, poisoning, iatrogenic, respiratory, gastro intestinal, neurological, dermatological, muscular, renal, urological and reproductive diseases, disorders or conditions; and diagnostic culture preparations for diagnosis of congenital, neoplastic, infective, traumatic, metabolic, endocrine, cardio-vascular, hematological, degenerative, auto immune, inflammatory, allergic, poisoning, iatrogenic, respiratory, gastro intestinal, neurological, dermatological, muscular, renal, urological and reproductive diseases, disorders or conditionsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 6, 2002C8..CANCELLED SEC. 8 (6-YR)—
Mar 28, 1995R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 1, 1994PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 30, 1994NPUBNOTICE OF PUBLICATION—
Aug 1, 1994CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 6, 19941.BDSec. 1(B) CLAIM DELETED—
May 6, 1994CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 9, 1994CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 25, 1994CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 6, 1993CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 3, 1993CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 5, 1993CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 6, 1993DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance